Etanercept News and Research

RSS
Etanercept (Enbrel) is a drug that treats autoimmune diseases by interfering with the TNF receptor (a part of the immune system) by acting as a TNF inhibitor.
Arthritis patients still suffer as drugs guidelines are ignored

Arthritis patients still suffer as drugs guidelines are ignored

Experts call for improved access to treatment for psoriatic arthritis

Experts call for improved access to treatment for psoriatic arthritis

Tumour Necrosis Factor alpha (TNF-alpha) blocking agents cause skin disease

Tumour Necrosis Factor alpha (TNF-alpha) blocking agents cause skin disease

Wyeth responds to patent lawsuit ruling

Wyeth responds to patent lawsuit ruling

Biologic therapies are changing the way dermatologists treat psoriasis

Biologic therapies are changing the way dermatologists treat psoriasis

Enbrel to treat rheumatoid arthritis approved in Japan

Enbrel to treat rheumatoid arthritis approved in Japan

Trial of Etanercept for Wegners's disease shows no benefit against the autoimmune condition

Trial of Etanercept for Wegners's disease shows no benefit against the autoimmune condition

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

Enbrel therapy allowed more rheumatoid arthritis patients to achieve clinical remission

Enbrel therapy allowed more rheumatoid arthritis patients to achieve clinical remission

FDA approves new drug Enbrel for psoriasis

FDA approves new drug Enbrel for psoriasis